Abstract
Wnt/β-catenin signaling is essential for intestinal homeostasis and is aberrantly activated in most colorectal cancers (CRC) through mutation of the tumor suppressor Adenomatous Polyposis Coli (APC). APC is an essential component of a cytoplasmic protein complex that targets β-catenin for destruction. Following Wnt ligand presentation, this complex is inhibited. However, a role for APC in this inhibition has not been shown. Here, we utilized Wnt3a-beads to locally activate Wnt co-receptors. In response, the endogenous β-catenin destruction complex reoriented toward the local Wnt cue in CRC cells with full-length APC, but not if APC was truncated or depleted. Non-transformed human colon epithelial cells displayed similar Wnt-induced destruction complex localization which appeared to be dependent on APC and less so on Axin. Our results expand the current model of Wnt/β-catenin signaling such that in response to Wnt, the β-catenin destruction complex: (1) maintains composition and binding to β-catenin, (2) moves toward the plasma membrane, and (3) requires full-length APC for this relocalization.
Subject terms: Colon cancer, Extracellular signalling molecules
Introduction
The Wnt signaling pathway is essential for cell proliferation, cell polarity, developmental cell-fate determination, and tissue homeostasis1. As a result, deregulation of Wnt signaling is often associated with cancer and other diseases2,3. Notably, over 90% of colorectal cancers (CRC) have mutations that activate the Wnt pathway with over 80% containing mutations in the Wnt antagonist Adenomatous Polyposis Coli (APC)4. Human APC mutations commonly arise in a central region of the open reading frame, referred to as the “mutation cluster region” (MCR, Fig. 1a), resulting in a truncated protein product5. APC truncation results in loss of multiple β-catenin binding sites (20R), Axin interaction sites (SAMP), nuclear localization sequences, and a C-terminal basic region which mediates cytoskeletal interactions (Fig. 1a). Germline or sporadic APC mutations in colon stem cells lead to polyp formation and are considered initiating events in colorectal tumorigenesis6,7. In the context of Wnt signaling, it is well established that APC acts as a scaffold in the β-catenin destruction complex. Given that other proteins involved in this complex could be altered to activate Wnt signaling, it is curious that APC mutations predominate in CRCs. One potential explanation for this is that APC performs additional critical functions both inside and outside the context of Wnt signaling.
The canonical Wnt pathway serves to regulate the level of transcriptional coactivator β-catenin8,9. To prevent aberrant transcriptional activation in the absence of Wnt, a cytoplasmic β-catenin destruction complex composed of APC, Axin, CK1-α, and GSK-3β maintains low levels of β-catenin through sequestration, phosphorylation, and β-TrCP-mediated ubiquitination, leading to proteasomal degradation10–12. However, if a Wnt ligand binds the co-receptors Frizzled (FZD) and low-density lipoprotein receptor 5/6 (LRP5/6) to form the heterotrimeric “signalosome,” the β-catenin destruction complex is inhibited through an incompletely resolved mechanism13,14. While the downstream effects of Wnt signaling have been extensively analyzed, the specific molecular events which cause destruction complex inhibition are not well understood. Further, the exact roles of APC in normal destruction complex function have remained elusive, and it has not been determined whether APC is also involved in promoting the transduction of a Wnt signal.
Wnt ligands are required for intestinal stem cell (ISC) self-renewal and crypt homeostasis15–17. Traditionally, these intestinal Wnt ligands have been thought to diffuse from the crypt base toward the luminal surface to form a signaling gradient. However, Wnt was recently shown to predominantly engage with FZD receptors on the ISCs that were immediately adjacent to Wnt-secreting cells and not those that were further removed from the Wnt source. These findings are inconsistent with a Wnt diffusion model, but instead support a model whereby Wnt is initially bound to receptors following secretion and forms a gradient through receptor turnover and cell division18. Therefore, intestinal Wnt signaling may convey positional information within the crypt and direct intracellular protein localization based on the location of the Wnt source. In the current study, we will examine the effect of a local, immobilized Wnt signal on colon epithelial cells.
Several challenges have historically limited our understanding of Wnt signaling dynamics as it relates to intestinal homeostasis in the normal and cancerous state. Due to the widespread use of the ApcMin/+ mouse model, much focus has been directed to the small intestine rather than the colon, the site of most tumor-initiating APC mutations in humans19. Further, very little is known about Wnt signaling in colon epithelial cells that are from non-malignant origin, as most studies utilize only cultured CRC cell lines. Finally, prior research has mostly relied on overexpression of specific Wnt pathway components or cells treated with soluble Wnt in the media, limiting the ability to elucidate endogenous β-catenin destruction complex dynamics in response to a local Wnt signal (reviewed in3).
Here, we examine the response of endogenous β-catenin destruction complex components to a locally presented Wnt signal in human colon epithelial cells of both malignant and non-malignant origin. We demonstrate for the first time that a localized Wnt source can recruit the signalosome and β-catenin destruction complex in colon epithelial cells and find that this Wnt-induced recruitment requires full-length APC. Our work identifies a novel role for APC in the regulation of destruction complex movement toward the membrane following Wnt exposure.
Results
Wild-type APC, but not truncated mutant APC is recruited toward local Wnt3a in human colon cancer cells
Since APC is mutated in >80% of colorectal cancers and is a major scaffolding protein for the β-catenin destruction complex, we first asked whether APC redistributes toward a localized Wnt3a signal in a panel of human CRC cell lines. Three colon cancer cell lines, each with a different Wnt pathway status, were used: RKO (intact Wnt signaling pathway), HCT116βm (WT APC, stabilized β-catenin due to Ser45 deletion)20, and DLD1 cells (APC truncation at amino acid 1452, WT β-catenin, see Fig. 1a). Previous studies relied on Wnt addition to cell culture media, thus limiting the ability to examine responses to a localized stimulus. To address this issue and examine endogenous protein response to a locally applied Wnt source – we treated cells with Wnt3a-conjugated or Unloaded-beads.
Cells treated for 12–14 hours with Wnt- or Unloaded-beads were fixed and stained for APC (Fig. 1b). Protein localization was scored as: (A) toward the bead, (B) away from the bead, or (C) no obvious protein polarization (Fig. 1c). Scoring results were validated with line-scan analysis. Full-length APC localized toward the Wnt3a-bead in 76% of RKO (Fig. 1d) and 80% of HCT116βm cells (Fig. 1e). In contrast, truncated APC localized toward the Wnt-bead in only 53% of DLD-1 cells (Fig. 1f). In all cases, the majority of cells treated with Unloaded-beads displayed random distribution of APC, suggesting that physical contact with an Unloaded-bead is not sufficient to re-orient APC. These data demonstrate that Wnt exposure induces APC re-localization toward the Wnt source in multiple human CRC lines. Furthermore, this process appears to be compromised in cells carrying truncated APC but remains functional in cells with an activated Wnt/β-catenin transcriptional program due to stabilized β-catenin. The phenotypic consequences of truncated APC have been previously postulated to act in a “just-right” signaling model, in which truncated APC retains partial β-catenin regulatory function to allow a specific level of Wnt activation21. Because truncated APC shows reduced ability to localize toward a Wnt source, it is possible that this partial localization is a method to obtain a precise level of Wnt-response.
Wnt components are recruited toward localized Wnt3a in cells with an intact Wnt signaling pathway
Since APC is a key scaffold for the β-catenin destruction complex, we reasoned that additional members of the destruction complex and signalosome may also localize near a Wnt-bead. RKO cells with an intact Wnt signaling pathway were treated with beads and then stained for the scaffolding protein Axin1, kinases CK1-α and GSK-3β, the Wnt receptor FZD7, the ubiquitin ligase β-TrCP, and β-catenin. FZD7 was chosen for its defined role in gastrointestinal homeostasis22–24.
Distinct Axin1 puncta were observed near the Wnt-bead (Fig. 2a). While RKO cells contain low levels of β-catenin due to an intact Wnt pathway, they do have visible β-catenin staining which can be scored. Treatment with Unloaded-beads failed to induce relocalization of β-catenin (Fig. 2b). However, in cells treated with a Wnt-bead, β-catenin levels increase and β-catenin localized toward the bead (Fig. 2b). Of note, the ubiquitin ligase β-TrCP also localized toward the bead (Fig. 2f). These findings suggest that upon Wnt/FZD binding, the cytoplasmic destruction complex relocates to the membrane and is able to recruit β-TrCP but falls short of targeting β-catenin for destruction. This result is consistent with a model proposed by Li et al. whereby the destruction complex saturates with β-catenin, leaving newly synthesized β-catenin to control downstream Wnt target gene expression following Wnt stimulation25. The kinases CK1-α and GSK-3β were also detected near the Wnt-bead (Fig. 2c,d), as was the Wnt receptor FZD7 (Fig. 2e).
To test for a physical interaction between the Wnt-coated beads and destruction complex components, the beads were used to “pull down” Wnt and associated proteins from lysates of Wnt-bead-treated cells. APC and β-catenin each associated more with Wnt-beads than with Unloaded-beads (Fig. 3). Together, these data demonstrate that signalosome and destruction complex proteins concentrate near a local Wnt3a cue and do not fully disassemble in response to ~12 hour exposure to a Wnt3a bead. Furthermore, these data support a model in which β-catenin remains associated with the destruction complex following Wnt stimulation.
Stabilized β-catenin does not impact Wnt component localization in response to Wnt3a
In colorectal cancer, mutations in the APC and β-catenin encoding genes appear to be mutually exclusive. Though most CRCs have APC mutations, about half of the small subset of colorectal cancers with wild-type APC harbor mutations that activate β-catenin26. These mutations typically result in loss of specific β-catenin residues whose phosphorylation is critical for ubiquitin conjugation and proteasome-mediated destruction. To determine whether such “stabilizing” β-catenin mutations would compromise orientation of Wnt signaling components toward a localized Wnt3a, we examined HCT116βm cells. Unlike the parental HCT116 cells, which express both wild-type and mutant β-catenin, HCT116βm possess only one mutant β-catenin allele encoding a Ser45 deletion20. Ser45 phosphorylation by CK1-α primes the successive phosphorylation of Thr41, Ser37, and Ser33 by GSK-3β, a prerequisite for recognition and ubiquitination by β-TrCP10–12. Note that APC localized toward the Wnt-bead in both RKO and HCT116βm cells (Fig. 1d,e).
As seen in RKO cells, Axin1 localized in distinct puncta near the Wnt-bead in HCT116βm cells (Fig. 4a). Despite expressing only stabilized β-catenin, HCT116βm cells exhibited both CK1-α and GSK-3β localized toward the Wnt-bead (Fig. 4c,d). This finding demonstrates that CK1-α recruitment to the destruction complex is not dependent on Ser45 of β-catenin, nor is GSK-3β recruitment dependent on Ser45 phosphorylation. FZD7 was also detected near the Wnt-bead (Fig. 4e). Notably, β-catenin also localized near the Wnt-bead (Fig. 4b), suggesting that the destruction complex maintains association with stabilized β-catenin, even in the absence of degradation. On the other hand, β-TrCP failed to localize toward the Wnt-bead in HCT116βm cells (Fig. 4f), demonstrating that β-catenin Ser45 is necessary for β-TrCP association with the destruction complex. Therefore, β-TrCP does not appear to be an inherent member of the destruction complex, but rather, is recruited following β-catenin phosphorylation. Together, these results demonstrate that an activated Wnt pathway through β-catenin stabilization is not sufficient to block orientation of core destruction complex proteins toward localized Wnt. β-TrCP failed to localize toward the Wnt cue, consistent with CK1-α phosphorylation of β-catenin as a prerequisite for β-TrCP recruitment.
Cells lacking full-length APC are compromised for Wnt component localization toward Wnt
Both HCT116βm and DLD1 cells possess an activated Wnt/β-catenin transcriptional program, induced by mutation of β-catenin or APC, respectively. As described, with the exception of β-TrCP, Wnt pathway components remained able to orient toward a localized Wnt source in HCT116βm cells (Fig. 4). DLD1 cells have a mutation in the mutation cluster region that leads to a truncated APC protein lacking the Axin-binding SAMP motifs and most of the β-catenin-binding 20aa repeats (Fig. 1a). However, this truncated APC was reported to co-precipitate with Axin1, suggesting that it maintains its scaffolding properties25. Given that truncated APC appeared compromised for orientation toward a Wnt-bead in DLD1 cells (Fig. 1f), we asked whether other β-catenin destruction complex members also displayed diminished localization toward a Wnt3a source.
If APC only serves as a destruction complex scaffold, then we would expect normal destruction complex orientation in DLD1 cells. Instead, we found that Axin1 localization to the Wnt3a-bead was detected in only 30% of DLD-1 cells (Fig. 5a), compared to 61% of RKO cells (Fig. 2a) and was not significantly different than localization to the Unloaded-bead. GSK-3β and β-TrCP were also compromised for Wnt-bead orientation in DLD1 cells (Fig. 5d,f). Of all proteins analyzed in DLD1 cells, only CK1-α and FZD7 were localized toward the Wnt-bead more than the Unloaded-bead (Fig. 5c,e). However, even this Wnt-bead localization was observed much less frequently in DLD1 cells than in RKO or HCT116βm cells, which contain full-length APC. Subcellular β-catenin reorientation could not be assessed by visual inspection of DLD1 cells due to overall high protein levels. However, line scan analyses demonstrated that β-catenin also failed to relocate in response to a Wnt-bead (Fig. S3).
Together, these results indicate that full-length APC is necessary for optimal destruction complex orientation in response to a Wnt cue. Given that truncated APC co-precipitates with Axin1 and the destruction complex in DLD1 cells25, our results also suggest that APC mediates destruction complex localization by a mechanism independent of, or in addition to, its role as a scaffold for the complex. Truncated APC in DLD1 cells lacks domains that bind dynein27, kinesin28, and microtubules27–30. These interactions potentially contribute to movement of the destruction complex toward the Wnt source. However, because localization of FZD7 and CK1-α toward the Wnt-bead was decreased, but still present, it appears that truncated APC retains some ability to localize the complex or that alternative mechanisms may be able to localize these proteins in the absence of full-length APC.
APC loss impairs Wnt-induced destruction complex reorientation
Given that the β-catenin destruction complex localized toward a Wnt-bead in CRC cell lines with wild-type APC but was impaired in cells with truncated APC, we hypothesized that destruction complex localization requires full-length APC. To test the APC-dependence of Wnt-induced destruction complex localization, we utilized RKO-APCKO cells, generated through CRISPR/Cas9 by Lee and colleagues31. Immunofluorescent microscopy revealed reduced APC signal in RKO-APCKO cells compared to the parental RKO cell line (Fig. 6a). While parental RKO cells displayed Wnt-induced localization of β-catenin in 70% of cells scored (Fig. 2b), this localization was seen in only 25% of the RKO-APCKO cells (Fig. 6b,e). Further, Axin1 and GSK-3β failed to relocalize toward a Wnt-bead in the RKO-APCKO cells (Fig. 6c,f,d,g). These data demonstrate that Wnt-induced destruction complex localization in CRC cells is dependent on APC.
Wnt triggers destruction complex reorientation in normal human colonic epithelial cells in an APC-dependent manner
In normal colon tissue, adult stem cells facilitate the continual regeneration of the epithelial lining and rely on Wnt ligand for maintenance of the stem cell niche. Having observed Wnt-mediated re-localization of the β-catenin destruction complex in human colon cancer cell lines, we wondered if normal human colon stem cells also displayed this property and if so, whether this relocalization was APC-dependent. To address this, we sought human colonic epithelial cells (HCECs) that were isolated from normal tissue and propagated in culture under near physiological conditions (low oxygen and sera). Shay and colleagues isolated HCECs from routine colonoscopy and immortalized them with expression of cyclin-dependent kinase 4 (Cdk4) and human telomerase (hTERT)32. These “HCEC 1CT” cells also express endogenous stem cell markers and are able to differentiate into multiple cell lineages making them a unique and valuable model of normal colon epithelial stem cells.
Using HCEC 1CT cells, we depleted APC levels with siRNA (siAPC) and then determined localization of β-catenin, Axin1 and GSK3β. APC knock-down was efficient in HCEC 1CT and resulted in increased β-catenin protein levels, as expected (Fig. 7a). In cells treated with scrambled siRNA (siCtl), Wnt-bead exposure resulted in re-orientation of APC, β-catenin, Axin1, and GSK-3β toward the Wnt source (Fig. 7b–i). Therefore, normal non-transformed human colonic epithelial cells maintain the ability to re-orient the β-catenin destruction complex toward a Wnt cue. Remarkably, APC knock-down resulted in complete loss of β-catenin, Axin1, and GSK-3β orientation toward the Wnt-bead (Fig. 7c–e,g–i). Distinct β-catenin puncta were visualized near Wnt-beads in siCtl HCEC 1CT cells. In contrast, β-catenin levels were increased with diffuse cytoplasmic staining and prominent nuclear localization in HCEC 1CT cells depleted of APC but lacked localization toward the Wnt-bead (siAPC, Fig. 7c). These data are in agreement with the findings in RKO-APCKO cells (Fig. 6).
Like APC, Axin1 is a key scaffolding protein in the β-catenin destruction complex, and thus, might control proper localization of the complex. Using HCEC 1CT cells, we depleted Axin1 with siRNA (siAxin1) and determined the localization of APC and β-catenin. Both APC and β-catenin still localized toward the Wnt-bead in Axin1-depleted HCEC 1CT cells (Fig. 7l,m). However, this bead-induced redistribution did appear to be slightly compromised compared to that seen in siCtl HCEC 1CT cells. Given that APC-depletion resulted in complete loss of localization of destruction complex components, we conclude that APC is necessary and sufficient for Wnt-induced localization of the destruction complex, while Axin1 can enhance the localization, but is expendable.
Together, these data demonstrate that the β-catenin destruction complex retains the ability to orient toward a localized Wnt source in HCEC 1CT cells and reveal a requirement and novel function of full-length APC in destruction complex trafficking toward a Wnt cue.
Discussion
To investigate the role of APC in Wnt-directed destruction complex localization, we first explored signalosome and destruction complex response in commonly used CRC cell lines with varying Wnt pathway status. The data from these experiments provide novel findings that the β-catenin destruction complex re-localizes toward Wnt in colon epithelial cells and that this redistribution is impaired in DLD1 cells expressing a truncated form of APC. Truncated APC is present in the majority of human CRC, and results in loss of the C-terminal half of APC, which contains domains involved in destruction complex assembly, nuclear localization, and cytoskeletal interactions. Further, we demonstrate that APC loss ablates Wnt-induced destruction complex localization. Unlike the parental RKO cell line, Axin1, GSK-3β and β-catenin are unable to localize toward a Wnt-bead in RKO-APCKO cells. We extended this study to a non-transformed human colon epithelial cell line which exhibits stem cell characteristics and found that Wnt-directed destruction complex localization also occurs in colon epithelial cells of non-malignant origin. When compared to the protein distribution in DLD1 cells, which were already limited in signalosome and destruction complex reorientation in response to localized Wnt, APC depletion in the non-transformed human colon epithelial cells completely abolished Wnt-induced destruction complex localization. Combined with a previous report that the truncated APC found in DLD1 remains associated with destruction complex protein Axin125, it appears that APC utilizes its function in scaffolding as well as interactions in the C-terminus to fully traffic the destruction complex toward a Wnt cue.
Numerous models of the events following Wnt receptor activation have been proposed, however the specific molecular proceedings that occur are still debated due to the use of overexpression of Wnt pathway components, global addition of Wnt to culture media, or the wide range of cell and tissue types used. Many models propose that the destruction complex is either inactivated or partially disassembled following Wnt/co-receptor interaction3,33–36. However, other studies have demonstrated that some of the destruction complex may be targeted to the plasma membrane following receptor activation25,37,38. Recently, an elegant study exposed mouse embryonic stem cells to Wnt3a-conjugated beads, resulting in APC, β-catenin, and LRP6 localization toward a Wnt-bead and also found that the local Wnt cue could trigger asymmetric cell division39. To our knowledge, this is the only study examining the orientation of signalosome and destruction complex components in response to localized Wnt and was performed in pluripotent cells of nonhuman origin and limited to three endogenous proteins.
Our study builds upon the current model of Wnt signal transduction and brings to light a new role for APC. Here, we report the requirement of APC for proper Wnt-induced localization of the β-catenin destruction complex in both malignant CRC cell lines and in non-transformed colon epithelial cells. In contrast to our findings, others have demonstrated that key members of the complex are degraded or endocytosed following prolonged Wnt exposure25,31,40–42. It is possible that these differences reflect more spatially restricted Wnt contact in our study compared to global Wnt exposure. It also seems likely that the bead attached to Wnt ligand in our study was so large as to prohibit endocytosis. Potentially related, recent evidence points to a role for the central region of APC in preventing clathrin-mediated endocytosis in the Wnt-off state31. Over time, the complexity of potential APC functions related to Wnt signaling has been gradually revealed. Previous work by our lab and others demonstrated that APC performs roles outside of its classically defined scaffolding function in the β-catenin destruction complex. For example, APC interaction with nuclear β-catenin leads to repression of Wnt target genes through several potential mechanisms: providing access to the transcriptional corepressor CtBP or the E3 ligase β-TrCP, β-catenin sequestration from transcriptional coactivator LEF-1/TCF, or facilitating β-catenin’s nuclear export43–47.
Together, our results suggest a novel mechanism of β-catenin destruction complex regulation by the APC protein (Fig. 8). In addition to its well-established role as a negative regulator of cytoplasmic β-catenin, we show that APC is also responsible for moving the β-catenin destruction complex to the cell membrane following Wnt exposure. We demonstrate for the first time that the endogenous β-catenin destruction complex reorients toward a localized Wnt signal in an APC-dependent manner in human colon epithelial cells of both normal and malignant origin. Finally, our data support a model whereby the destruction complex remains assembled and bound to β-catenin following Wnt ligand presentation. Because β-catenin accumulates in Wnt-treated cells, it appears that this β-catenin-bound complex is unable to effectively degrade β-catenin. Perhaps APC helps release modified β-catenin from the destruction complex, thereby enabling its proteasomal degradation as previously proposed25. Another possibility, is that Wnt stimulation leads to an APC-dependent membrane orientation of the destruction complex which results in complex inactivation. Upon removal of Wnt signal, this already assembled complex would be unlocked and able to process β-catenin for destruction. These two models are not mutually exclusive and might even be interdependent.
Future studies are necessary to clarify the precise mechanism of APC-regulated destruction complex trafficking to the membrane. Or study does not support an absolute requirement for Axin1 in Wnt-mediated destruction complex relocalization. Perhaps Axin2, a Wnt target, is able to compensate for Axin1 in this capacity. Axin has been postulated to localize to Wnt receptors following Wnt activation through a Dvl-dependent mechanism48. Based on the compromised destruction complex localization observed in DLD1 cells and APC-depleted HCEC 1CT cells, we suggest that APC is required for Axin docking to membrane-associated Dvl following Wnt exposure. In this light, our results strongly support the model proposed by Tacchelly-Benites et al., based on studies in Drosophila, that APC plays a major role in regulating Axin’s signalosome recruitment in response to Wnt signaling by facilitating phosphorylation of Axin by GSK-3β49. The compromised localization observed in DLD1 cells suggests that C-terminal domains contribute to this trafficking, potentially through cytoskeletal interactions27–30,50,51. The mechanism by which APC moves the β-catenin destruction complex toward the signalosome is a necessary focus for future studies in order to provide insight into colon epithelial cell biology and further elucidate unknown aspects of Wnt signal transduction. Overall, our findings provide additional mechanistic details of destruction complex behavior following Wnt exposure, and uncover a novel role for APC in Wnt signal transduction.
Materials and Methods
Cell culture and treatments
RKO, HCT116βm, DLD1, and RKO-APCKO cells were cultured in DMEM (with L-Glutamine and 4.5 g/L Glucose; without Sodium Pyruvate) supplemented with 10% FBS and were maintained at 37 °C and 5% CO2. HCEC 1CT cells were generously provided by Dr. Jerry Shay, UT-Southwestern and cultured as described previously in X-media (4:1 DMEM/Medium 199) supplemented with EGF (20 ng/ml), hydrocortisone (1 μg/ml), insulin (10 μg/ml), apo-transferrin (2 μg/ml), sodium selenite (5 nM), and 2% cosmic calf serum32. Cells were maintained at 37 °C in low-oxygen incubators to reduce stress-induced senescence from normal atmospheric oxygen tension and to better recapitulate physiological conditions, as described previously52. For immunofluorescence assays, cells were seeded onto fibronectin/Poly-D-Lysine coated coverglass (Neuvitro) at 25% confluence and incubated at least 24 hrs prior to treatment with 5 μl beads/well for 12–14 hrs. HCEC 1CT cells were seeded at 10–15% confluence prior to siRNA transfection and Wnt-bead treatment.
For siRNA-mediated inhibition, HCEC 1CT cells were transfected using Lipofectamine 3000 (Invitrogen) according to the manufacturer’s instructions with 37.5 nM of each siRNA targeting human APC (Smartpool siRNAs 1–3; Dharmacon), human Axin1 (Smartpool siRNA 4; Dharmacon) or nontargeting siControl siRNA (Dharmacon). Cell media was changed one day following siRNA transfection, and cells were grown 48 hrs prior to Wnt-bead or Unloaded-bead treatment.
Immobilization of Wnt protein
Wnt3a was immobilized onto Dynabeads as described previously39. Briefly, 2.8 μm Dynabeads M-270 Carboxylic Acid (Invitrogen) were activated by NHS/EDC (Sigma, 50 mg/ml each in cold 25 mM MES pH 5) then washed three times with cold MES buffer. Wnt immobilization was performed by diluting 0.5 μg of purified Wnt3a protein (Peprotech, #315-20) in cold MES buffer and incubated at room temperature (RT) for 1 hr. To quench non-reactive carboxylic acid groups, beads were incubated with 50 mM Tris pH 7.4 at RT for 15 min. Beads were washed twice in PBS pH 7.4 before final resuspension in 400 μl PBS/0.5% BSA and stored at 4 °C. Unloaded-beads were prepared in parallel by incubating 1 hr in MES without Wnt. Wnt3a activity following bead immobilization was verified using a TOPflash luciferase reporter assay53.
Immunofluorescence
Cells were briefly rinsed in PBS prior to fixation. Cells were fixed in 4% PFA in Brinkley’s Buffer 1980 (80 mM PIPES pH 6.8, 1 mM MgCl2, 1 mM EGTA) for 20 min at RT, washed two times in PBS prior to permeabilization in TBS/0.2% Triton X-100 for 5 min. Cells were washed in TBS two times prior to incubation for 1 hr at RT in blocking buffer containing TBS/0.2% Triton X-100, 1% BSA, and 3% Normal Goat Serum. Primary and secondary antibodies were incubated for 1 hr at RT. Cells were washed in TBS three times following primary and secondary antibody incubations. Coverslips were mounted and counterstained with Prolong Diamond Antifade Mountant with DAPI (Invitrogen). Staining of FZD7 was performed without cell permeabilization or use of detergent to keep the cell membrane intact. Nuclei were counterstained with 5 μg/ml Hoechst 33342 (Invitrogen) in PBS for 5–10 min prior to mounting with Prolong Antifade (Invitrogen). Antibodies were diluted in blocking buffer as follows: anti-APC-M2 rabbit pAb (1:4,00054), anti-Axin1 rabbit mAb (1:500, Cell Signaling, #2087), anti-β-catenin mouse mAb (1:250, BD Transduction Laboratories, #610154), anti-CK1α rabbit pAb (1:500, Bethyl Laboratories, #A301–991A), anti-GSK3β rabbit pAb (1:500, Bethyl Laboratories, #A302-049A), anti-β-TrCP rabbit pAb (1:500, Abcam, #71753), and anti-Frizzled-7 rabbit pAb (1:500, EMD Millipore, #06-1063), Alexa Fluor 488 and 568 conjugated secondary antibodies (1:1,000, Invitrogen). Stained cells were examined using an Axioplan microscope (Zeiss) with a X100 objective. Images of stained cells were captured using an Orca R2 digital camera (Hamamatsu).
Immunoblotting
Cells were washed 1x in PBS prior to harvesting in pre-heated high-salt sample lysis buffer (20% glycerol, 2% SDS, 30% 10x PBS, 2.5% β-mercaptoethanol). Scraped cells were transferred to Eppendorf tubes, heated at 95 °C for 1 min, pulled through an insulin syringe three times, and heated again. Samples were separated on 7.5% SDS-PAGE (Bio-Rad, TGX FastCast Acrylamide Kit) using Tris-Glycine running buffer and transferred to a nitrocellulose membrane (GE) with a 0.45-μm pore size. Antibodies were diluted in Odyssey Blocking Buffer TBS (LI-COR) as follows: anti-APC-M2 rabbit pAb (1:2,000), anti-β-catenin mouse mAb (1:1,000), anti-Axin1 goat (1:500, R&D Systems #AF3287), and anti-β-actin mouse mAb (Sigma) (1:1,000), IRDye 680LT and 800CW anti-rabbit or anti-mouse secondary antibodies (1:15,000). Immunoblots were imaged on a LI-COR Odyssey CLx imaging system.
Wnt-bead pull-down
Cells were grown in 6-well tissue culture plates and treated with 40 μl Unloaded-beads or Wnt-beads for four hours. Following bead treatment, cells were briefly washed in 1x PBS prior to lysis in 200 μl lysis buffer, described previously (150 mM NaCl, 30 mM Tris pH 7.5, 1 mM EDTA, 1% Triton X-100, 10% glycerol, 0.1 mM PMSF, 0.5 mM DTT, and HALT protease and phosphatase inhibitors)25. After addition of lysis buffer, cells were scraped into 1.5 ml tubes and rotated at 4 °C for 30 min. Beads were isolated using a magnet and the supernatant was transferred to a new tube. Beads were washed three times in 500 μl of cold lysis buffer. Following the final wash, beads were resuspended in 40 μl cold PBS and 20 μl 3X SDS sample buffer. Samples were analyzed by western blot as described above.
Line scan analysis
ImageJ/FIJI (National Institutes of Health, Bethesda, MD) was used for line scan analyses to quantify protein localization in relation to a Wnt- or Unloaded-bead. Line width was set to 50, corresponding to approximately the size of a Dynabead. Lines were drawn beginning at the bead and across the cell, moving through and across the center of the nucleus. For graphical presentation in (Fig. 1c–e), each scan was set to zero by subtracting the lowest intensity value across the line. At least five representative cells were measured per condition. Refer to Supplemental Figs. S1–S3 for line scan analysis of RKO, HCT116βm, and DLD1 cells.
Statistical analysis
Blinded scoring was performed on a subset of samples using the scoring system presented in Fig. 1a. Slides were covered and numbered prior to scoring and imaging, and decoded following completion of each experiment. Experiments were performed a minimum of three times with at least 25 cells scored per condition per experiment. T-tests (two-tailed) were performed using GraphPad Prism 8 to determine statistical significance between score frequency in Wnt-bead and Unloaded-bead groups as well as between control siRNA and APC siRNA samples in the HCEC 1CT experiments.
Supplementary information
Acknowledgements
The authors thank J. Shay and K. Batten (UT-Southwestern Medical Center) for generous technical advice and supply of the HCEC 1CT cell line. We thank E. Lee (Vanderbilt) for providing the RKO-APCKO cell line. We thank D. Dixon (University of Kansas) for reading and providing comments during manuscript preparation. This study was supported by the National Science Foundation [grant number IOS-1456538] and by the National Institutes of Health [P30CA168524] to K.L.N.
Author contributions
T.W.P. and K.L.N. designed and performed experiments, analyzed the data, and wrote and edited the manuscript.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
is available for this paper at 10.1038/s41598-020-59899-z.
References
- 1.Logan CY, Nusse R. The Wnt Signaling Pathway in Development and Disease. Annu. Rev. Cell Dev. Biol. 2004;20:781–810. doi: 10.1146/annurev.cellbio.20.010403.113126. [DOI] [PubMed] [Google Scholar]
- 2.Clevers H. Wnt/β-Catenin Signaling in Development and Disease. Cell. 2006;127:469–480. doi: 10.1016/j.cell.2006.10.018. [DOI] [PubMed] [Google Scholar]
- 3.MacDonald BT, Tamai K, He X. Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases. Dev. Cell. 2009;17:9–26. doi: 10.1016/j.devcel.2009.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.The Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337. doi: 10.1038/nature11252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Mori Y, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet. 1992;1:229–233. doi: 10.1093/hmg/1.4.229. [DOI] [PubMed] [Google Scholar]
- 6.Barker N, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457:608–611. doi: 10.1038/nature07602. [DOI] [PubMed] [Google Scholar]
- 7.Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767. doi: 10.1016/0092-8674(90)90186-I. [DOI] [PubMed] [Google Scholar]
- 8.Hatzis P, et al. Genome-Wide Pattern of TCF7L2/TCF4 Chromatin Occupancy in Colorectal Cancer Cells. Mol. Cell. Biol. 2008;28:2732–2744. doi: 10.1128/MCB.02175-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Watanabe Kazuhide, Biesinger Jacob, Salmans Michael L., Roberts Brian S., Arthur William T., Cleary Michele, Andersen Bogi, Xie Xiaohui, Dai Xing. Integrative ChIP-seq/Microarray Analysis Identifies a CTNNB1 Target Signature Enriched in Intestinal Stem Cells and Colon Cancer. PLoS ONE. 2014;9(3):e92317. doi: 10.1371/journal.pone.0092317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997;16:3797–3804. doi: 10.1093/emboj/16.13.3797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kitagawa M, et al. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J. 1999;18:2401–2410. doi: 10.1093/emboj/18.9.2401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Liu C, et al. Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism. Cell. 2002;108:837–847. doi: 10.1016/S0092-8674(02)00685-2. [DOI] [PubMed] [Google Scholar]
- 13.Bilić J, et al. Wnt Induces LRP6 Signalosomes and Promotes Dishevelled-Dependent LRP6 Phosphorylation. Science. 2007;316:1619–1622. doi: 10.1126/science.1137065. [DOI] [PubMed] [Google Scholar]
- 14.Tamai K, et al. LDL-receptor-related proteins in Wnt signal transduction. Nature. 2000;407:530. doi: 10.1038/35035117. [DOI] [PubMed] [Google Scholar]
- 15.Clevers H, Loh KM, Nusse R. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science. 2014;346:1248012. doi: 10.1126/science.1248012. [DOI] [PubMed] [Google Scholar]
- 16.van Es JH, et al. A Critical Role for the Wnt Effector Tcf4 in Adult Intestinal Homeostatic Self-Renewal. Mol. Cell. Biol. 2012;32:1918–1927. doi: 10.1128/MCB.06288-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Korinek V, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 1998;19:379–383. doi: 10.1038/1270. [DOI] [PubMed] [Google Scholar]
- 18.Farin HF, et al. Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. Nature. 2016;530:340–343. doi: 10.1038/nature16937. [DOI] [PubMed] [Google Scholar]
- 19.Zeineldin M, Neufeld KL. More than two decades of Apc modeling in rodents. Biochim. Biophys. Acta BBA - Rev. Cancer. 2013;1836:80–89. doi: 10.1016/j.bbcan.2013.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Chan TA, Wang Z, Dang LH, Vogelstein B, Kinzler KW. Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation. Proc. Natl. Acad. Sci. 2002;99:8265–8270. doi: 10.1073/pnas.082240999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Albuquerque C, et al. The ‘just-right’ signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade. Hum. Mol. Genet. 2002;11:1549–1560. doi: 10.1093/hmg/11.13.1549. [DOI] [PubMed] [Google Scholar]
- 22.Flanagan DJ, et al. Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations. Cancer Res. 2019;79:970–981. doi: 10.1158/0008-5472.CAN-18-2095. [DOI] [PubMed] [Google Scholar]
- 23.Flanagan DJ, et al. Loss of the Wnt receptor frizzled 7 in the mouse gastric epithelium is deleterious and triggers rapid repopulation in vivo. Dis. Model. Mech. 2017;10:971–980. doi: 10.1242/dmm.029876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Flanagan DJ, et al. Frizzled7 Functions as a Wnt Receptor in Intestinal Epithelial Lgr5+ Stem Cells. Stem Cell Rep. 2015;4:759–767. doi: 10.1016/j.stemcr.2015.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Li VSW, et al. Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex. Cell. 2012;149:1245–1256. doi: 10.1016/j.cell.2012.05.002. [DOI] [PubMed] [Google Scholar]
- 26.Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer. Cancer Res. 1998;58:1130–1134. [PubMed] [Google Scholar]
- 27.Gao FJ, et al. Insulin signaling regulates a functional interaction between adenomatous polyposis coli and cytoplasmic dynein. Mol. Biol. Cell. 2017;28:587–599. doi: 10.1091/mbc.e16-07-0555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ruane, P. T. et al. Tumour Suppressor Adenomatous Polyposis Coli (APC) localisation is regulated by both Kinesin-1 and Kinesin-2. Sci. Rep. 6 (2016). [DOI] [PMC free article] [PubMed]
- 29.Dikovskaya D, et al. Microtubule assembly by the Apc protein is regulated by importin-β—RanGTP. J. Cell Sci. 2010;123:736–746. doi: 10.1242/jcs.060806. [DOI] [PubMed] [Google Scholar]
- 30.Munemitsu S, et al. The APC Gene Product Associates with Microtubules in Vivo and Promotes Their Assembly in Vitro. Cancer Res. 1994;54:3676–3681. [PubMed] [Google Scholar]
- 31.Saito-Diaz K, et al. APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev. Cell. 2018;44:566–581.e8. doi: 10.1016/j.devcel.2018.02.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Roig AI, et al. Immortalized Epithelial Cells Derived From Human Colon Biopsies Express Stem Cell Markers and Differentiate In Vitro. Gastroenterology. 2010;138:1012–1021.e5. doi: 10.1053/j.gastro.2009.11.052. [DOI] [PubMed] [Google Scholar]
- 33.Lee E, Salic A, Krüger R, Heinrich R, Kirschner MW. The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway. PLOS Biol. 2003;1:e10. doi: 10.1371/journal.pbio.0000010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Liu X, Rubin JS, Kimmel AR. Rapid, Wnt-Induced Changes in GSK3β Associations that Regulate β-Catenin Stabilization Are Mediated by Gα Proteins. Curr. Biol. 2005;15:1989–1997. doi: 10.1016/j.cub.2005.10.050. [DOI] [PubMed] [Google Scholar]
- 35.Luo W, et al. Protein phosphatase 1 regulates assembly and function of the β-catenin degradation complex. EMBO J. 2007;26:1511–1521. doi: 10.1038/sj.emboj.7601607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Roberts DM, et al. Deconstructing the ßcatenin destruction complex: mechanistic roles for the tumor suppressor APC in regulating Wnt signaling. Mol. Biol. Cell. 2011;22:1845–1863. doi: 10.1091/mbc.e10-11-0871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Mao J, et al. Low-Density Lipoprotein Receptor-Related Protein-5 Binds to Axin and Regulates the Canonical Wnt Signaling Pathway. Mol. Cell. 2001;7:801–809. doi: 10.1016/S1097-2765(01)00224-6. [DOI] [PubMed] [Google Scholar]
- 38.Zeng X, et al. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature. 2005;438:873. doi: 10.1038/nature04185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Habib SJ, et al. A Localized Wnt Signal Orients Asymmetric Stem Cell Division in Vitro. Science. 2013;339:1445–1448. doi: 10.1126/science.1231077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Blitzer JT, Nusse R. A critical role for endocytosis in Wnt signaling. BMC Cell Biol. 2006;7:28. doi: 10.1186/1471-2121-7-28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Gagliardi M, Hernandez A, McGough IJ, Vincent J-P. Inhibitors of endocytosis prevent Wnt/Wingless signalling by reducing the level of basal β-catenin/Armadillo. J. Cell Sci. 2014;127:4918–4926. doi: 10.1242/jcs.155424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Yamamoto H, Komekado H, Kikuchi A. Caveolin Is Necessary for Wnt-3a-Dependent Internalization of LRP6 and Accumulation of β-Catenin. Dev. Cell. 2006;11:213–223. doi: 10.1016/j.devcel.2006.07.003. [DOI] [PubMed] [Google Scholar]
- 43.Neufeld KL, Zhang F, Cullen BR, White RL. APC-mediated downregulation of -catenin activity involves nuclear sequestration and nuclear export. EMBO Rep. 2000;1:519–523. doi: 10.1093/embo-reports/kvd117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Neufeld KL, et al. Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc. Natl. Acad. Sci. 2000;97:12085–12090. doi: 10.1073/pnas.220401797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rosin-Arbesfeld R, Cliffe A, Brabletz T, Bienz M. Nuclear export of the APC tumour suppressor controls β-catenin function in transcription. EMBO J. 2003;22:1101–1113. doi: 10.1093/emboj/cdg105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Rosin-Arbesfeld R, Townsley F, Bienz M. The APC tumour suppressor has a nuclear export function. Nature. 2000;406:1009. doi: 10.1038/35023016. [DOI] [PubMed] [Google Scholar]
- 47.Sierra J, Yoshida T, Joazeiro CA, Jones KA. The APC tumor suppressor counteracts β-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 2006;20:586–600. doi: 10.1101/gad.1385806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Zeng X, et al. Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development. 2008;135:367–375. doi: 10.1242/dev.013540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Tacchelly-Benites O, et al. Axin phosphorylation in both Wnt-off and Wnt-on states requires the tumor suppressor APC. Plos Genet. 2018;14:e1007178. doi: 10.1371/journal.pgen.1007178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Moseley JB, et al. Regulated Binding of Adenomatous Polyposis Coli Protein to Actin. J. Biol. Chem. 2007;282:12661–12668. doi: 10.1074/jbc.M610615200. [DOI] [PubMed] [Google Scholar]
- 51.Rosin-Arbesfeld R, Ihrke G, Bienz M. Actin-dependent membrane association of the APC tumour suppressor in polarized mammalian epithelial cells. EMBO J. 2001;20:5929–5939. doi: 10.1093/emboj/20.21.5929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Wright WE, Shay JW. Inexpensive low-oxygen incubators. Nat. Protoc. 2006;1:2088. doi: 10.1038/nprot.2006.374. [DOI] [PubMed] [Google Scholar]
- 53.Korinek V, et al. Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma. Science. 1997;275:1784–1787. doi: 10.1126/science.275.5307.1784. [DOI] [PubMed] [Google Scholar]
- 54.Wang Y, Azuma Y, Friedman DB, Coffey RJ, Neufeld KL. Novel association of APC with intermediate filaments identified using a new versatile APC antibody. BMC Cell Biol. 2009;10:75. doi: 10.1186/1471-2121-10-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.